The MEK1/2-IRF4 axis fosters T follicular helper cell differentiationand antitumor humoral immune response
Journal of Translational Medicine · 16.03.2026 · 24 (1)
DOI: 10.1186/s12967-026-08023-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Medicine, online erschienen am 16.03.2026. Verfasst von Shuan Ran und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Immunity, Humoral, Interferon Regulatory Factors, Cell Differentiation, MAP Kinase Kinase 2. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Emerging evidence has underscored the significance of antitumor humoral immunity, which is associated with the development of T follicular helper (Tfh) cell. However, the molecular mechanisms underlying Tfh differentiation in antitumor immunity remains poorly understood.
Methods
We analyzed publicly available RNA-seq data across various representative immune models to identify signature pathways of Tfh cells. Subsequently, we generated T-cell-specific Mek 1/2 knockout mice and investigated the functional phenotypes through Tfh cell polarization, adoptive transfer, and flow cytometry assays. Next, we employed multi-omics sequencing and overexpression experiments to delineate the underlying mechanisms of cellular phenotypes. Finally, by integrated analysis of scRNA-seq datasets combined with MEK inhibitor intervention studies, we elucidated the anti-tumor humoral responses of MEK inhibitors in both murine tumor models and TCGA-SKCM patient cohort.
Results
Mitogen-activated protein kinase kinase 1/2 (MEK1/2) signaling was identified as a potential regulator of Tfh cells and antitumor humoral response. Codeletion or pharmacological inhibition of MEK1/2 effectively promoted Tfh cell development in vitro and in vivo. Mechanistically, ATAC-seq and RNA-seq integrative analysis revealed interferon regulatory factor 4 (IRF4)-dependent epigenetic modulation of characteristic Tfh cell genes, thereby driving Tfh differentiation. Overexpression of Irf4 counteracted Mek 1/2 ablation-mediated Tfh cell generation. Moreover, MEK1/2 inhibitor therapy enhanced Tfh infiltration coupled with humoral immune responses in murine melanoma model and was correlated with favorable clinical prognosis in melanoma patients.
Conclusions
Our study revealed the MEK1/2-IRF4 axis potentiates Tfh development to enhance the antitumor humoral response. These findings may provide an unprecedented strategy to improve antitumor immunotherapy efficacy by harnessing humoral immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Center for Translational Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. jacobcjk@163.com.
- Center for Translational Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. jacobcjk@163.com.
- Key Laboratory of Organ Transplantation, NHC Key Laboratory of Organ Transplantation; Ministry of Education; , Chinese Academy of Medical Sciences, Wuhan, China. jacobcjk@163.com.
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wujie426@hust.edu.cn.
Zitieren
APA
Ran, S., Wang, S., Li, R., Lai, L., Yu, J., Zhang, X., Li, Y., Ye, W., Zong, J., Li, X., Hao, Y., Zhao, J., Luo, Z., Zhang, H., Zheng, K., Huang, P., Zhan, W., Zou, Z., Zou, Y., …, & Xia, J. (2026). The MEK1/2-IRF4 axis fosters T follicular helper cell differentiationand antitumor humoral immune response. Journal of Translational Medicine, 24(1). https://doi.org/10.1186/s12967-026-08023-2
Vancouver
Ran S, Wang S, Li R, Lai L, Yu J, Zhang X, et al. The MEK1/2-IRF4 axis fosters T follicular helper cell differentiationand antitumor humoral immune response. Journal of Translational Medicine. 2026;24(1). doi:10.1186/s12967-026-08023-2
BibTeX
@article{Ran2026,
author = {Ran, Shuan and Wang, Song and Li, Ran and Lai, Longyong and Yu, Jizhang and Zhang, Xi and Li, Yuan and Ye, Weicong and Zong, Junjie and Li, Xiaohan and Hao, Yanglin and Zhao, Jiulu and Luo, Zilong and Zhang, Han and Zheng, Kexiao and Huang, Pinyan and Zhan, Wang and Zou, Zifeng and Zou, Yanqiang and Cui, Jikai and Wu, Jie and Xia, Jiahong},
title = {The MEK1/2-IRF4 axis fosters T follicular helper cell differentiationand antitumor humoral immune response},
journal = {Journal of Translational Medicine},
year = {2026},
volume = {24},
number = {1},
doi = {10.1186/s12967-026-08023-2}
}
EUVIMED